TrioMed is pleased to announce the appointment of Mark Bondin as its new General Manager.

Mr Bondin has played a pivotal role in the company’s growth journey, initially leading the Medical Devices Business Unit at Prohealth Limited and later overseeing the consolidated TrioMed business following its acquisition. His strategic direction and commitment have significantly contributed to the company’s expansion and success.

"Mark's leadership, vision, and dedication have been instrumental in shaping TrioMed’s success. This new role reflects both his expanding responsibilities and the continued impact he is making in driving innovation and excellence," said Peter Apap, CEO & Co-founder of Prohealth Limited.

"We are confident that under his guidance, TrioMed will continue to grow and deliver exceptional value to our partners and clients."

Mark Bondin shared his thoughts on the appointment: “It’s been incredibly rewarding to be part of TrioMed’s evolution, and I look forward to continue building on our strong foundation. Together with the team, we will keep pushing boundaries to deliver innovative solutions and lasting value to our clients and partners."